Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 6
2008 4
2009 10
2010 8
2011 3
2012 4
2013 2
2014 4
2015 6
2016 4
2017 6
2018 11
2019 13
2020 9
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Extremity Dysfunction After Large-Bore Radial and Femoral Arterial Access.
Meijers TA, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen MT, Rathore S, van der Schaaf RJ, Knaapen P, Dens J, Iglesias JF, Agostoni P, Roolvink V, Lemmert ME, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: van der schaaf rj. J Am Heart Assoc. 2022 Jan 18;11(2):e023691. doi: 10.1161/JAHA.121.023691. Epub 2022 Jan 13. J Am Heart Assoc. 2022. PMID: 35023343 Free article.
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention.
Meijers TA, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen MT, Rathore S, van der Schaaf RJ, Knaapen P, Dens J, Iglesias JF, Agostoni P, Roolvink V, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: van der schaaf rj. JACC Cardiovasc Interv. 2021 Jun 28;14(12):1293-1303. doi: 10.1016/j.jcin.2021.03.041. Epub 2021 May 18. JACC Cardiovasc Interv. 2021. PMID: 34020929
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Fagel ND, Amoroso G, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JP, Patterson MS, Oosterwerff EFJ, Vos NS, Verheugt FWA, Tijssen JGP, de Winter RJ, Riezebos RK. Fagel ND, et al. Among authors: van der schaaf rj. Am Heart J. 2021 Apr;234:42-50. doi: 10.1016/j.ahj.2021.01.001. Epub 2021 Jan 7. Am Heart J. 2021. PMID: 33422517 Clinical Trial.
Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol.
Meijers TA, Aminian A, Teeuwen K, van Wely M, Schmitz T, Dirksen MT, van der Schaaf RJ, Iglesias JF, Agostoni P, Dens J, Knaapen P, Rathore S, Ottervanger JP, Dambrink JE, Roolvink V, Gosselink ATM, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: van der schaaf rj. BMJ Open. 2020 Jul 20;10(7):e038042. doi: 10.1136/bmjopen-2020-038042. BMJ Open. 2020. PMID: 32690749 Free PMC article.
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ, Elias J, van Dongen IM, Tijssen RYG, Koch KT, Baan J Jr, Vis MM, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS; AIDA Investigators. Wykrzykowska JJ, et al. Among authors: van der schaaf rj. N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29. N Engl J Med. 2017. PMID: 28402237 Free article. Clinical Trial.
Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
Niehe SR, Vos NS, Van Der Schaaf RJ, Amoroso G, Herrman JR, Patterson MS, Slagboom T, Vink MA. Niehe SR, et al. Among authors: van der schaaf rj. J Invasive Cardiol. 2022 Jan;34(1):E39-E42. Epub 2021 Nov 18. J Invasive Cardiol. 2022. PMID: 34792482 Free article. Clinical Trial.
Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
Serruys PW, Katagiri Y, Sotomi Y, Zeng Y, Chevalier B, van der Schaaf RJ, Baumbach A, Smits P, van Mieghem NM, Bartorelli A, Barragan P, Gershlick A, Kornowski R, Macaya C, Ormiston J, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Windecker S, Byrne RA, Räber L, van Geuns RJ, Mintz GS, Onuma Y. Serruys PW, et al. Among authors: van der schaaf rj. J Am Coll Cardiol. 2017 Jul 4;70(1):60-74. doi: 10.1016/j.jacc.2017.05.028. J Am Coll Cardiol. 2017. PMID: 28662808 Free article. Clinical Trial.
Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial.
Kerkmeijer LSM, Renkens MPL, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout KE, Weevers APJD, Garcia-Garcia HM, Kraak R, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: van der schaaf rj. EuroIntervention. 2021 Aug 31:EIJ-D-21-00419. doi: 10.4244/EIJ-D-21-00419. Online ahead of print. EuroIntervention. 2021. PMID: 34483094 Free article.
93 results